MedCity Influencers

Defensive medicine has little to do with malpractice fears (Best of MedCitizens)

Every week, MedCity News highlights the best of its MedCitizens: syndication partners and MedCity News readers who discuss life science current events on MedCityNews.com. Now here’s the best of what YOU had to say: the truth behind defensive medicine, Medtronic-Edwards fight moves to the courts, a new vision for genome studies, and health IT defense for the medical community.

Every week, MedCity News highlights the best of its MedCitizens: syndication partners and MedCity News readers who discuss life science current events on MedCityNews.com.

Now here’s the best of what YOU had to say:

Patient test follow-up often lacking. “If med mal reform happened tomorrow, I’d be willing to bet plenty of excessive testing would still occur and that some other excuse would be given to explain it. Only payment reform, provider education and changes in patient demand are likely to make a big difference.”

Medtronic, Edwards Lifesciences to continue battling beyond court system. “The protracted battle over transcatheter heart valves between Medtronic Inc. (NYSE:MDT) and Edwards Lifesciences Inc. (NYSE:EW) will be decided in the streets rather than the courts.”

New medical treatments, more accurate diagnoses to come from genome studies. “A new strategic plan from an arm of the National Institutes of Health envisions scientists being able to identify genetic bases of most single-gene disorders and gaining new insights into multi-gene disorders in the next decade. This should lead to more accurate diagnoses, new drug targets and the development of practical treatments for many who today lack therapeutic options, according to the plan from the National Human Genome Research Institute (NHGRI).”

Health IT security requires multi-layered defense. “Clinicians are mobile people. They work in ambulatory offices, hospitals, skilled nursing facilities, on the road, and at home. They have desktops, laptops, tablets, iPhones and iPads. Ideally their applications should run everywhere on everything. That’s the reason we’ve embraced the web for all our built and bought applications. Protecting these web applications from the evils of the internet is a challenge.”

Chris Seper runs MedCityNews.com and contributes regularly to the site. He is the vice president of healthcare for Breaking Media, MedCity's corporate owners. Reach him at [email protected].

This post appears through the MedCity Influencers program. Anyone can publish their perspective on business and innovation in healthcare on MedCity News through MedCity Influencers. Click here to find out how.

Topics